Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities

被引:12
作者
Borde, Shambhavi [1 ]
Matosevic, Sandro [1 ,2 ]
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47906 USA
基金
美国国家卫生研究院;
关键词
CANCER MICROENVIRONMENT; IFN-GAMMA; INHIBITION; MATURATION; TRANSCRIPTION; ACTIVATION; CHECKPOINT; TARGET; GROWTH; MCT1;
D O I
10.1016/j.tips.2023.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The adaptation of natural killer (NK) cells to conditions in the microenvironment of tumors is deeply affected by their metabolic activity, itself a result of nutrient availability and the metabolism of the cancer cells themselves. Elevated rates of glycolysis and lipid metabolism in cancers not only lead to the accumulation of immunosuppressive byproducts but also contribute to an environment of elevated concentrations of extracellular metabolites. This results in altered NK cell bioenergetics through changes in transcriptional and translational profiles, ultimately affecting their pharmacology and impairing NK cell responses. However, understanding the metabolic processes that drive alterations in immunological signaling on NK cells remains both difficult and vastly underexplored. We discuss the varied and complex drivers of NK cell metabolism in homeostasis and the tumor microenvironment (TME), challenges associated with their targetability, and unexplored therapeutic opportunities.
引用
收藏
页码:832 / 848
页数:17
相关论文
共 131 条
[11]   CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations? [J].
Battastini, Ana Maria Oliveira ;
Figueiro, Fabricio ;
Leal, Daniela Bitencourt Rosa ;
Doleski, Pedro Henrique ;
Schetinger, Maria Rosa Chitolina .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[12]   The metabolism of cells regulates their sensitivity to NK cells depending on p53 status [J].
Belkahla, Sana ;
Brualla, Joaquin Marco ;
de Maudave, Alexis Fayd'herbe ;
Falvo, Paolo ;
Allende-Vega, Nerea ;
Constantinides, Michael ;
Khan, Abrar Ul Haq ;
Coenon, Lois ;
Alexia, Catherine ;
Mitola, Giulia ;
Massa, Paul ;
Orecchioni, Stefania ;
Bertolini, Francesco ;
Mnif, Wissem ;
Hernandez, Javier ;
Anel, Alberto ;
Villalba, Martin .
SCIENTIFIC REPORTS, 2022, 12 (01)
[13]   Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration [J].
Beloueche-Babari, Mounia ;
Galobart, Teresa Casals ;
Delgado-Goni, Teresa ;
Wantuch, Slawomir ;
Parkes, Harold G. ;
Tandy, Debbie ;
Harker, James A. ;
Leach, Martin O. .
BRITISH JOURNAL OF CANCER, 2020, 122 (06) :895-903
[14]   Safety and efficacy of the anti-CD73 monoclonal antibody (mAb) oleclumab ± durvalumab in patients (pts) with advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), or EGFR-mutant non-small cell lung cancer (EGFRm NSCLC). [J].
Bendell, Johanna C. ;
LoRusso, Patricia ;
Overman, Michael J. ;
Noonan, Anne M. ;
Kim, Dong-Wan ;
Strickler, John ;
Kim, Sang-We ;
Clarke, Stephen John ;
George, Thomas J. ;
Grimison, Peter S. ;
Barve, Minal A. ;
Amin, Manik A. ;
Desai, Jayesh ;
Wise-Draper, Trisha ;
Cooper, Zachary ;
Elgeioushi, Nairouz ;
Mueller, Nancy Kathryn ;
Kumar, Rakesh ;
Wu, Kevin YuFeng ;
Patel, Sandip Pravin .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[15]   Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD plus Depletion in Cancer Cells [J].
Benjamin, Don ;
Robay, Dimitri ;
Hindupur, Sravanth K. ;
Pohlmann, Jens ;
Colombi, Marco ;
El-Shemerly, Mahmoud Y. ;
Maira, Sauveur-Michel ;
Moroni, Christoph ;
Lane, Heidi A. ;
Hall, Michael N. .
CELL REPORTS, 2018, 25 (11) :3047-+
[16]   Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity [J].
Bernard, Pierre-Louis ;
Delconte, Rebecca ;
Pastor, Sonia ;
Laletin, Vladimir ;
Da Silva, Cathy Costa ;
Goubard, Armelle ;
Josselin, Emmanuelle ;
Castellano, Remy ;
Krug, Adrien ;
Vernerey, Julien ;
Devillier, Raynier ;
Olive, Daniel ;
Verhoeyen, Els ;
Vivier, Eric ;
Huntington, Nicholas D. ;
Nunes, Jacques ;
Guittard, Geoffrey .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
[17]   TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells [J].
Bi, Jiacheng ;
Huang, Chen ;
Jin, Xiaomeng ;
Zheng, Chaoyue ;
Huang, Yingying ;
Zheng, Xiaohu ;
Tian, Zhigang ;
Sun, Haoyu .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
[18]   Tumor acidity: From hallmark of cancer to target of treatment [J].
Bogdanov, Alexey ;
Bogdanov, Andrey ;
Chubenko, Viacheslav ;
Volkov, Nikita ;
Moiseenko, Fedor ;
Moiseyenko, Vladimir .
FRONTIERS IN ONCOLOGY, 2022, 12
[19]   LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells [J].
Brand, Almut ;
Singer, Katrin ;
Koehl, Gudrun E. ;
Kolitzus, Marlene ;
Schoenhammer, Gabriele ;
Thiel, Annette ;
Matos, Carina ;
Bruss, Christina ;
Klobuch, Sebastian ;
Peter, Katrin ;
Kastenberger, Michael ;
Bogdan, Christian ;
Schleicher, Ulrike ;
Mackensen, Andreas ;
Ullrich, Evelyn ;
Fichtner-Feigl, Stefan ;
Kesselring, Rebecca ;
Mack, Matthias ;
Ritter, Uwe ;
Schmid, Maximilian ;
Blank, Christian ;
Dettmer, Katja ;
Oefner, Peter J. ;
Hoffmann, Petra ;
Walenta, Stefan ;
Geissler, Edward K. ;
Pouyssegur, Jacques ;
Villunger, Andreas ;
Steven, Andre ;
Seliger, Barbara ;
Schreml, Stephan ;
Haferkamp, Sebastian ;
Kohl, Elisabeth ;
Karrer, Sigrid ;
Berneburg, Mark ;
Herr, Wolfgang ;
Mueller-Klieser, Wolfgang ;
Renner, Kathrin ;
Kreutz, Marina .
Cell Metabolism, 2016, 24 (05) :657-671
[20]   Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment [J].
Cekic, Caglar ;
Day, Yuan-Ji ;
Sag, Duygu ;
Linden, Joel .
CANCER RESEARCH, 2014, 74 (24) :7250-7259